Effects of cellular redox balance on induction of apoptosis by eicosapentaenoic acid in HT29 colorectal adenocarcinoma cells and rat colon in vivo

BACKGROUND AND AIMS Epidemiological evidence suggests n-3 polyunsaturated lipids may protect against colorectal neoplasia. Consumption of fish oil modulates crypt cytokinetics in humans, and crypt apoptosis in animal models. To explore these effects, we investigated involvement of caspase enzymes and cellular redox balance in the induction of apoptosis by eicosapentaenoic acid (EPA) in HT29 cells, and in rat colon in vivo. METHODS Survival of HT29 cells grown with EPA in the presence of caspase inhibitors, antioxidants, or buthionine sulphoximine, an inhibitor of glutathione neosynthesis, was determined. The effects of EPA enriched fish oil and glutathione depletion on apoptosis in rat colon were assessed using microdissected crypts. RESULTS Treatment of HT29 cells with EPA reduced viable cell number and activated caspase 3, prior to cell detachment. Antioxidants and caspase inhibitors blocked HT29 cell death whereas glutathione depletion increased it. Rats fed fish oil had higher crypt cell apoptosis than those fed corn oil, and glutathione depletion enhanced this effect. CONCLUSIONS Incorporation of EPA into colonic epithelial cell lipids increases apoptosis. The results of this study, using both an animal and cell line model, support the hypothesis that this effect is mediated via cellular redox tone, and is sensitive to glutathione metabolism. The data suggest a mechanism whereby polyunsaturated fatty acids may influence the susceptibility of colorectal crypt cells to induction or progression of neoplasia.

[1]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[2]  S. Goodman,et al.  Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac , 1999, Gut.

[3]  R. Clarke,et al.  Effect of eicosapentaenoic acid on the proliferation and incidence of apoptosis in the colorectal cell line HT29 , 1999, Lipids.

[4]  D. Voehringer.  BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity. , 1999, Free radical biology & medicine.

[5]  J. Houghton.  Apoptosis and drug response. , 1999, Current opinion in oncology.

[6]  M. Mattson,et al.  Caspase and calpain substrates: Roles in synaptic plasticity and cell death , 1999, Journal of neuroscience research.

[7]  T. Aw.  Molecular and cellular responses to oxidative stress and changes in oxidation-reduction imbalance in the intestine. , 1999, The American journal of clinical nutrition.

[8]  E. Levy,et al.  Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP) , 1999, Cell Death and Differentiation.

[9]  I. H. Engels,et al.  Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. , 1999, Blood.

[10]  I. Johnson,et al.  Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon. , 1999, Carcinogenesis.

[11]  D. Winton,et al.  Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Solary,et al.  Fas Ligand-independent, FADD-mediated Activation of the Fas Death Pathway by Anticancer Drugs* , 1999, The Journal of Biological Chemistry.

[13]  M. Madesh,et al.  Apoptotic process in the monkey small intestinal epithelium: I. Association with glutathione level and its efflux. , 1999, Free radical biology & medicine.

[14]  S. Orrenius,et al.  Redox Regulation of the Caspases during Apoptosis a , 1998, Annals of the New York Academy of Sciences.

[15]  Junji Kato,et al.  Aberrant crypt foci of the colon as precursors of adenoma and cancer , 1998, The New England journal of medicine.

[16]  E. Solary,et al.  Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis , 1998, Oncogene.

[17]  J. Morrow,et al.  Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. , 1998, Cancer research.

[18]  M. Arends,et al.  Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism , 1998, The Journal of pathology.

[19]  D. A. Hughes,et al.  Use of argentation TLC with GC to resolve C18:1 fatty acid isomers in test and commercial spreads. , 1998, Biochemical Society transactions.

[20]  J. Lupton,et al.  Biochemical and Molecular Roles of Nutrients Fish Oil Blocks Azoxymethane-Induced Rat Colon Tumorigenesis by Increasing Cell Differentiation and Apoptosis Rather Than Decreasing Cell Proliferation , 1998 .

[21]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[22]  G. Piazza,et al.  Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. , 1997, Cancer research.

[23]  J. Lupton,et al.  Predictive Value of Proliferation, Differentiation and Apoptosis as Intermediate Markers for Colon Tumorigenesis , 2022 .

[24]  E. Germain,et al.  Suppression of the promoter effect of polyunsaturated fatty acids by the absence of dietary vitamin E in experimental mammary carcinoma. , 1997, Cancer letters.

[25]  C. Paraskeva,et al.  In vitro models for studying colorectal carcinogenesis: cellular and molecular events including APC and Rb cleavage in the control of proliferation, differentiation and apoptosis. , 1996, Biochimica et biophysica acta.

[26]  F. Giardiello,et al.  Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors. , 1996, Gut.

[27]  U. Das,et al.  Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells in vitro. , 1995, Prostaglandins, leukotrienes, and essential fatty acids.

[28]  I. Johnson,et al.  Validation of a simple technique for the detection of abnormal mucosal cell replication in humans , 1994, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[29]  I. Johnson,et al.  Polyunsaturated fatty acids of the n - 3 series influence intestinal crypt cell production in rats. , 1994, Carcinogenesis.

[30]  C. Sirtori,et al.  Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout. , 1993, Biochimica et biophysica acta.

[31]  A. Shamsuddin,et al.  Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid). , 1993, Carcinogenesis.

[32]  D. Epps,et al.  Interaction of antioxidants with depth-dependent fluorescence quenchers and energy transfer probes in lipid bilayers. , 1992, Chemistry and physics of lipids.

[33]  M. Anti,et al.  Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. , 1992, Gastroenterology.

[34]  Michael J. González,et al.  Effect of dietary fat on growth of MCF-7 and MDA-MB231 human breast carcinomas in athymic nude mice: relationship between carcinoma growth and lipid peroxidation product levels. , 1991, Carcinogenesis.

[35]  G. Cerniglia,et al.  Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. , 1990, Analytical biochemistry.

[36]  D F Horrobin,et al.  Selective killing of human cancer cells by polyunsaturated fatty acids. , 1985, Prostaglandins, leukotrienes, and medicine.

[37]  H. Sies,et al.  A novel biologically active selenoorganic compound--IV. Protective glutathione-dependent effect of PZ 51 (ebselen) against ADP-Fe induced lipid peroxidation in isolated hepatocytes. , 1985, Biochemical pharmacology.

[38]  E. Cadenas,et al.  A novel biologically active seleno-organic compound--I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen). , 1984, Biochemical pharmacology.

[39]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[40]  U. Das,et al.  Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites? , 1998, Prostaglandins, leukotrienes, and essential fatty acids.

[41]  A. Levine,et al.  Sequential and rapid activation of select caspases during apoptosis of normal intestinal epithelial cells. , 1998, The American journal of physiology.

[42]  R. Coffey,et al.  Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAF1/CIP1 via C/EBPβ , 1997, Nature Medicine.

[43]  O. Aruoma,et al.  The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. , 1989, Free radical biology & medicine.